A good argument, which isn't necessary for my concurrence.
"Why don't they switch to transgenics once they know they have a winner???"
There is the issue: "Why" = "stigma." We are speaking of human drugs produced from animal clones. Like it or not, skepticism abounds. The World is not composed of scientists.
The FDA decision on ATRYN HD will remove 90% of the stigma that the EMEA left behind. Positive DIC PII results shall remove all remaining traces when the value proposition smacks Wall Street in the face.
Frankly, I don't see us staying at this market cap for much longer; however, the big explosion may have to wait until late 2008. I'd be happy to rise steadily over 2008 until the exponential, inevitable, spike.
1. Topline results
2. Partnership (the milestone amounts will cause folks to take notice; I'm postulating, again, that these will exceed 3x GTC's current market cap!)
3. FDA approval
4. DIC positive results (hopefully)
IMO.